+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Abreva"

Herpes Labialis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Herpes Labialis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Abreva is a brand of topical cream used to treat cold sores caused by the herpes simplex virus. It is a type of infectious disease drug, which are medications used to treat infections caused by bacteria, viruses, fungi, and parasites. Abreva is the only over-the-counter drug approved by the U.S. Food and Drug Administration to treat cold sores. It works by blocking the virus from entering healthy cells and helps to reduce the duration of the outbreak. Abreva is available in many countries around the world and is widely used to treat cold sores. It is available in both cream and pump form, and is often used in combination with other treatments such as antiviral medications. The Abreva market is highly competitive, with many companies offering similar products. Some of the major players in the market include GlaxoSmithKline, Novartis, Pfizer, and Johnson & Johnson. Other companies include Sanofi, Merck, and Bayer. Show Less Read more